NYSE$ALUR
Allurion Technologies Inc · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Reported financial results for the fourth quarter and full year ended December 31, 2023, and reiterated 2024 guidance.
Allurion Technologies reported Q4 2023 revenue of $8.2 million, compared to $19.2 million for the same period in 2022. The company's cash and cash equivalents totaled $38 million as of December 31, 2023. They are reiterating the financial guidance it previously published for full year 2024.
- Reiterated 2024 guidance on procedural volume, revenue, gross margin, and cash burn.
- Fourth quarter revenue was $8.2 million and full year 2023 revenue was $53.5 million, consistent with preannouncement on January 8.
- Procedural volume, as estimated through new app users, increased by 30% over 2022.
- Completed enrollment in the AUDACITY pivotal trial ahead of schedule.
Headline financials
Revenue & EPS history
Allurion · Revenue · Quarterly
$8.24M
Forward guidance
For full year 2024, Allurion reiterates the financial guidance it previously published:
Tailwinds
- Anticipated procedural volumes growth of 20%, reflecting increased penetration in key direct markets and reallocation of marketing spend to more efficient channels
- Revenue of $60 to $65 million, reflecting 12-22% growth year-over-year
- Expected gross margins of 77-79%, reflecting durable pricing of our gastric balloon as well as initial commercialization efforts for the Allurion Virtual Care Suite SaaS product
- Targeted cash burn of approximately $30 million for the full year
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2023
+1.5%
Avg return
Earnings day
+0.8%
Avg return
5 days after
+63.8%
Avg return
30 days after
48%
10 / 21 earnings
Positive
+47.1%
Q4 2025
Best reaction
-43.7%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +25.0% | +25.1% | +1467.3% | |
| Q4 2025 | +47.1% | +35.3% | +47.1% | |
| Q3 2025 | +1.4% | -6.0% | +12.1% | |
| Q2 2025 | +0.8% | -8.1% | -16.3% | |
| Q1 2025 | +25.1% | +29.7% | +5.1% | |
| Q4 2024 | +0.3% | +3.2% | -22.8% | |
| Q3 2024 | -43.7% | -46.2% | -51.3% | |
| Q2 2024 | -12.7% | -17.0% | -20.8% | |
| Q1 2024 | -1.0% | -8.8% | -28.4% | |
| Q4 2023 | -11.9% | -11.0% | -5.2% | |
| Q3 2022 | +2.4% | +0.7% | -18.7% | |
| Q3 2023 | +6.7% | +2.4% | -15.9% | |
| Q2 2022 | -2.3% | +3.8% | -3.6% | |
| Q1 2023 | -2.3% | +3.8% | -3.6% | |
| Q2 2023 | -2.3% | +3.8% | -3.6% | |
| Q4 2022 | -2.3% | +3.8% | -3.6% | |
| Q1 2022 | +0.0% | +0.2% | +0.3% | |
| Q4 2021 | +0.1% | +0.3% | -0.1% | |
| Q3 2021 | -0.2% | +0.0% | +0.0% | |
| Q2 2021 | -0.1% | -0.5% | -1.3% | |
| Q1 2021 | +0.9% | +1.0% | +2.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro